Green Alpha Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$217K	Sell	28,138 -144	-0.5%	-$1.05K	0.21%	92
2025 Q4	$173K	Buy	28,282 +6,839	+32%	+$73.9K	0.16%	102
2025 Q3	$395K	Sell	21,443 -4,539	-17%	-$72.9K	0.38%	74
2025 Q2	$338K	Sell	25,982 -1,249	-5%	-$14.8K	0.32%	84
2025 Q1	$288K	Buy	+27,231	New	+$432K	0.31%	86
2024 Q2	–	Sell	-8,414	Closed	-$284K	–	139
2024 Q1	$284K	Buy	8,414 +20	+0.2%	+$709	0.21%	124
2023 Q4	$265K	Sell	8,394 -13,144	-61%	-$312K	0.19%	137
2023 Q3	$550K	Sell	21,538 -2,282	-10%	-$70.3K	0.42%	89
2023 Q2	$683K	Sell	23,820 -615	-3%	-$16.7K	0.45%	84
2023 Q1	$586K	Buy	24,435 +994	+4%	+$17.8K	0.41%	94
2022 Q4	$398K	Buy	23,441 +79	+0.3%	+$1.38K	0.33%	108
2022 Q3	$346K	Sell	23,362 -52,888	-69%	-$888K	0.29%	120
2022 Q2	$1.2M	Buy	76,250 +53,237	+231%	+$1.04M	0.28%	71
2022 Q1	$620K	Buy	23,013 +2,064	+10%	+$52.7K	0.42%	98
2021 Q4	$775K	Buy	20,949 +726	+4%	+$29.6K	0.52%	87
2021 Q3	$966K	Buy	20,223 +2,101	+12%	+$94.1K	0.67%	73
2021 Q2	$613K	Buy	+18,122	New	+$613K	0.42%	108